User:Basaryucel/sandbox

Bio Istanbul
==== Bio Istanbul is a sustainable biomedical community that is being built across approximately 200 hectares in the Başakşehir district of Istanbul, Turkey. Bio Istanbul will consist of a pediatric hospital; biomedical research center and innovation campus; medical university; all-through (K-12) school; performing arts center; retail zone with restaurants, cafes, and shopping; commercial office space; and a low-density residential area with 6,000 units. ====

Strategic Importance
==== Bio Istanbul is a major part of the ambitious vision that Turkey has set for itself by 2023 (the 100 year anniversary of the establishment of the Republic of Turkey), and beyond. The Turkish Government is committed to transforming Turkey into one of the 10 largest economies in the world and a leader in research and development. Bio Istanbul, with a total investment amount of approximately $2.2 billion, will serve more than 500 million people in the fields of medicine and sciences, with 12,000 residents and 10,000 medical, research, and biotechnology professionals. ====

Ownership and Management
==== Bio Istanbul is a public-private partnership between TOKI (Republic of Turkey Prime Ministry Housing Development Administration) and Bio City Development Company B.V., aiming to develop the largest biomedical research park and biomedical innovation cluster in Turkey and the wider MENA region. ====

Location
==== Bio Istanbul is located at the center of the new development zone of Istanbul called “The New City”, in the Başakşehir district of Istanbul, 25 km west of the historic city center. Bio Istanbul is located 20 km from Atatürk Airport, Istanbul’s primary airport, and 25 km from the future site of Istanbul’s 3rd Airport. The Atatürk Olympic Stadium is located to the east of the site. The primary road currently serving the area is the Avrupa Otoyolu Highway (E80 or TEM), providing a direct link from the bridges and downtown to the newer areas of the city to the west. A major new highway known as the “3rd Bridge Road” is planned to the north of the site, with a highway exit serving Bio Istanbul directly. ====

Major Project Components
==== Istanbul Children’s Hospital will be 200-bed tertiary care pediatric hospital providing a full range of advanced clinical procedures. A 120-bed step-down facility will be attached to Istanbul Children’s Hospital to provide medically supervised short-stay facilities in a hotel-type environment, primarily for patients and their families. ====

==== Istanbul Biomedical Research Center (IBRC), a non-profit biomedical research center. IBRC will operate as a part intramural part virtual product development network of partners with its hub facility in Bio Istanbul. Partner organizations within and outside of Turkey will share an aligned mission and research mandate. The research focus area of IBRC will be non-communicable and chronic disease (NCD) with an initial emphasis on maternal and pediatric disease. NCDs present a large and rapidly increasing burden on the health of children and adults in emerging and advanced economies alike, and are responsible for far more deaths and illness than infectious diseases. IBRC will be the first international product development partnership whose specific mission will be to innovate healthcare technologies and products to combat non-communicable disease. In this context and as an additional element of its mission, IBRC is designed to attract the highly qualified Turkish scientific diaspora back to its origins in Turkey and strengthen Turkish research base on its path to transition onto a knowledge-based economy. ====

==== Innovation Campus will be the Research & Development hub of Bio Istanbul that will include eight fully integrated research laboratories, commercial R&D centers, offices, and incubation space. Focus primarily on biomedicine and alternative energy. These eight buildings will include hidden, underground car parking areas. IBRC is a leaseholder in the campus. ====

Bio Istanbul
==== Bio Istanbul is a sustainable biomedical community that is being built across approximately 200 hectares in the Başakşehir district of Istanbul, Turkey. Bio Istanbul will consist of a pediatric hospital; biomedical research center and innovation campus; medical university; all-through (K-12) school; performing arts center; retail zone with restaurants, cafes, and shopping; commercial office space; and a low-density residential area with 6,000 units. ====

Strategic Importance
==== Bio Istanbul is a major part of the ambitious vision that Turkey has set for itself by 2023 (the 100 year anniversary of the establishment of the Republic of Turkey), and beyond. The Turkish Government is committed to transforming Turkey into one of the 10 largest economies in the world and a leader in research and development. Bio Istanbul, with a total investment amount of approximately $2.2 billion, will serve more than 500 million people in the fields of medicine and sciences, with 12,000 residents and 10,000 medical, research, and biotechnology professionals. ====

Ownership and Management
==== Bio Istanbul is a public-private partnership between TOKI (Republic of Turkey Prime Ministry Housing Development Administration) and Bio City Development Company B.V., aiming to develop the largest biomedical research park and biomedical innovation cluster in Turkey and the wider MENA region. ====

Location
==== Bio Istanbul is located at the center of the new development zone of Istanbul called “The New City”, in the Başakşehir district of Istanbul, 25 km west of the historic city center. Bio Istanbul is located 20 km from Atatürk Airport, Istanbul’s primary airport, and 25 km from the future site of Istanbul’s 3rd Airport. The Atatürk Olympic Stadium is located to the east of the site. The primary road currently serving the area is the Avrupa Otoyolu Highway (E80 or TEM), providing a direct link from the bridges and downtown to the newer areas of the city to the west. A major new highway known as the “3rd Bridge Road” is planned to the north of the site, with a highway exit serving Bio Istanbul directly. ====

Major Project Components
==== Istanbul Children’s Hospital will be 200-bed tertiary care pediatric hospital providing a full range of advanced clinical procedures. A 120-bed step-down facility will be attached to Istanbul Children’s Hospital to provide medically supervised short-stay facilities in a hotel-type environment, primarily for patients and their families. ====

==== Istanbul Biomedical Research Center (IBRC), a non-profit biomedical research center. IBRC will operate as a part intramural part virtual product development network of partners with its hub facility in Bio Istanbul. Partner organizations within and outside of Turkey will share an aligned mission and research mandate. The research focus area of IBRC will be non-communicable and chronic disease (NCD) with an initial emphasis on maternal and pediatric disease. NCDs present a large and rapidly increasing burden on the health of children and adults in emerging and advanced economies alike, and are responsible for far more deaths and illness than infectious diseases. IBRC will be the first international product development partnership whose specific mission will be to innovate healthcare technologies and products to combat non-communicable disease. In this context and as an additional element of its mission, IBRC is designed to attract the highly qualified Turkish scientific diaspora back to its origins in Turkey and strengthen Turkish research base on its path to transition onto a knowledge-based economy. ====

==== Innovation Campus will be the Research & Development hub of Bio Istanbul that will include eight fully integrated research laboratories, commercial R&D centers, offices, and incubation space. Focus primarily on biomedicine and alternative energy. These eight buildings will include hidden, underground car parking areas. IBRC is a leaseholder in the campus. ====